Table 1 Patients and catheters chracteristics

123

(15)

103

(12)

321

(38)

255

(30)

21

(2)

Gender, male

51

(41)

52

(50)

178

(55)

120

(47)

18

(86)

Age, years

75

[65–86]

82

[64–88]

79

[64–87]

72

[63–85]

75

[70–87]

Body mass index, kg/m²

27

[23–31]

26

[22–30]

24

[22–27]

25

[23–29]

25

[23–28]

Antiseptic group

 2% chlorhexidine-alcohol

70

(57)

44

(43)

158

(49)

139

(55)

9

(43)

 5% povidone iodine-alcohol

53

(43)

59

(57)

163

(51)

116

(45)

12

(57)

Devices group

 Standard

67

(54)

55

(53)

152

(47)

110

(43)

12

(57)

 Innovative

56

(46)

48

(47)

169

(53)

144

(56)

9

(43)

Chronic disease^a

 Diabetes

39

(32)

17

(17)

62

(19)

43

(17)

6

(29)

 Dyslipidemia

26

(21)

11

(11)

71

(22)

53

(21)

4

(19)

 COPD

16

(13)

9

(9)

31

(10)

23

(9)

5

(24)

 Chronic heart failure

20

(16)

24

(23)

57

(18)

36

(14)

6

(29)

 Chronic renal failure

9

(7)

4

(4)

22

(7)

13

(5)

2

(10)

 Long-term corticosteroids

2

(2)

5

(5)

14

(4)

5

(2)

0

(0)

 Immune deficiency

4

(3)

0

(0)

7

(2)

3

(1)

1

(0)

 Haematological malignancy

2

(2)

5

(5)

10

(3)

4

(2)

0

(0)

 Autoimmune disease

4

(3)

1

(1)

12

(4)

11

(4)

0

(0)

 Unknown

20

(16)

19

(18)

43

(13)

34

(13)

6

(29)

 None

30

(24)

37

(36)

103

(32)

105

(41)

3

(14)

Antibiotics in the last 15 days

7

(6)

11

(11)

29

(9)

22

(9)

0

(0)

Number of catheter insertion attempts

1

[1–2]

1

[1–1]

1

[1–1]

1

[1–1]

1

[1–2]

Time with catheter in place, hours

43

[24–66]

39

[23–70]

42

[20–67]

32

[17–58]

47

[21–66]

Catheter colonization and/or local infection

9

(7)

16

(16)

21

(7)

28

(11)

1

(5)

Positive catheter tip culture

28

(23)

27

(26)

54

(17)

58

(23)

6

(29)